Evidence map›Paper›PMID 29368363›Full record

ArticleAddiction (Abingdon, England)2018

Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD.

Bertalan Németh, Judit Józwiak-Hagymásy, Gábor Kovács, Attila Kovács, Tibor Demjén, Manuel B Huber, Kei-Long Cheung, Kathryn Coyle, Adam Lester-George, Subhash Pokhrel and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Addiction (Abingdon, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bertalan NémethSyreon Research Institute, Budapest, Hungary.
Judit Józwiak-HagymásySyreon Research Institute, Budapest, Hungary.
Gábor KovácsKorányi National Institute of Tuberculosis and Pulmonology, Budapest, Hungary.
Attila KovácsNational Public Health and Medical Officer Service, Budapest, Hungary.
Tibor DemjénNational Institute for Health Development-Focal Point for Tobacco Control, Budapest, Hungary.
Manuel B HuberInstitute of Health Economics and Health Care Management, Helmholtz Zentrum München (GmbH) - German Research Center for Environmental Health, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Neuherberg, Germany.
Kei-Long CheungCAPHRI School of Public Health and Primary Care, Health Services Research, Maastricht University, Maastricht, the Netherlands.
Kathryn CoyleHealth Economics Research Group, Institute of Environment, Health and Societies, Brunel University London, London, UK.
Adam Lester-GeorgeLeLan (Ltd) Solutions, Bristol, UK.
Subhash PokhrelHealth Economics Research Group, Institute of Environment, Health and Societies, Brunel University London, London, UK.
Zoltán VokóSyreon Research Institute, Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo evaluate potential health and economic returns from implementing smoking cessation interventions in Hungary.

methodsThe EQUIPTMOD, a Markov-based economic model, was used to assess the cost-effectiveness of three implementation scenarios: (a) introducing a social marketing campaign; (b) doubling the reach of existing group-based behavioural support therapies and proactive telephone support; and (c) a combination of the two scenarios. All three scenarios were compared with current practice. The scenarios were chosen as feasible options available for Hungary based on the outcome of interviews with local stakeholders. Life-time costs and quality-adjusted life years (QALYs) were calculated from a health-care perspective. The analyses used various return on investment (ROI) estimates, including incremental cost-effectiveness ratios (ICERs), to compare the scenarios. Probabilistic sensitivity analyses assessed the extent to which the estimated mean ICERs were sensitive to the model input values.

resultsIntroducing a social marketing campaign resulted in an increase of 0.3014 additional quitters per 1 000 smokers, translating to health-care cost-savings of €0.6495 per smoker compared with current practice. When the value of QALY gains was considered, cost-savings increased to €14.1598 per smoker. Doubling the reach of existing group-based behavioural support therapies and proactive telephone support resulted in health-care savings of €0.2539 per smoker (€3.9620 with the value of QALY gains), compared with current practice. The respective figures for the combined scenario were €0.8960 and €18.0062. Results were sensitive to model input values.

conclusionsAccording to the EQUIPTMOD modelling tool, it would be cost-effective for the Hungarian authorities introduce a social marketing campaign and double the reach of existing group-based behavioural support therapies and proactive telephone support. Such policies would more than pay for themselves in the long term.

Indexed as

Models, EconomicAdultCost-Benefit AnalysisHumansHungaryProspective StudiesSmokingSmoking CessationCost-effectivenesseconomic modelHungarymodelingreturn-on-investment toolsmoking cessation

Identifiers

PMID29368363
PMCPMC6032939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.